Pfizer Limited Share Price Today
Techno Funda Ratings
Key Metrics
Current Price
₹4566.9Market Cap
₹ 20,893 Cr.Stock P/E
136ROE
19.8 %RSI
53.92Trend
BearishShare Price Chart
Technical Commentary
Buy or Sell Analysis
Company Overview
Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also has various independent contract/ third party manufacturers based across the country and sells its products through independent distributors primarily in India.[1] It is the 3rd largest multinational pharmaceutical company in India.[2]
Pfizer Ltd share price remains one of the actively tracked stocks on NSE among traders and long term investors.
The latest Pfizer Ltd share price NSE movement reflects ongoing investor interest driven by company fundamentals, sector performance and broader market sentiment.
From a technical analysis perspective, the Pfizer Ltd share price chart currently indicates a Bearish trend based on moving averages and RSI momentum analysis.
Technical Analysis
| Indicator | Value |
|---|---|
| Current Price | 4566.9 |
| RSI (14) | 53.92 |
| 50 DMA | 4588.73 |
| 200 DMA | 4854.55 |
| Trend | Bearish |
| A/D Rating | D |
| RS Rating | 24 |
| EPS Rating | 50 |
| TI65 | 1.01 |
| TI65 Trend | Neutral |
Pivot Points Analysis
Daily pivot points for Pfizer Limited calculated using previous trading session data. These levels help traders identify intraday support, resistance and breakout zones using Classic Pivot Point methodology.
Classic Pivot Points
| Level | Value |
|---|---|
| R3 | ₹4722.8 |
| R2 | ₹4665.9 |
| R1 | ₹4616.4 |
| PP | ₹4559.5 |
| S1 | ₹4510 |
| S2 | ₹4453.1 |
| S3 | ₹4403.6 |
Financial Ratios
| Metric | Value |
|---|---|
| Market Cap | ₹ 20,893 Cr. |
| Current Price | ₹ 4,567 |
| High / Low | ₹ 5,879 / 4,360 |
| Stock P/E | 136 |
| Book Value | ₹ 302 |
| Dividend Yield | 1.64 % |
| ROCE | 27.2 % |
| ROE | 19.8 % |
| Face Value | ₹ 10.0 |
Quarterly Results
| Quarter | Sales | Profit | OPM |
|---|
Shareholding Pattern
| Holder | Holding |
|---|---|
| Promoters | 63.92% |
| FIIs | 2.89% |
| DIIs | 10.53% |
| Public | 22.66% |
| No. of Shareholders | 85,570 |
Pros and Cons
Pros
- Healthy return on equity of 19.8% indicating strong capital allocation efficiency.
Cons
- Valuation metrics appear elevated with a trailing P/E of 136, demanding high performance requirements.
- Primary trend direction remains weak, stuck underneath major defensive supply barriers.
Related NSE Stocks
CIE Automotive India Limited
View Share Price Analysis →Sarda Energy & Minerals Limited
View Share Price Analysis →ACC Limited
View Share Price Analysis →HEG Limited
View Share Price Analysis →Emami Limited
View Share Price Analysis →Poonawalla Fincorp Limited
View Share Price Analysis →Chalet Hotels Limited
View Share Price Analysis →JM Financial Limited
View Share Price Analysis →Sun Pharmaceutical Industries Limited
View Share Price Analysis →SWAN CORP LIMITED
View Share Price Analysis →NHPC Limited
View Share Price Analysis →Graphite India Limited
View Share Price Analysis →Frequently Asked Questions
What is the current technical trend and RSI for Pfizer Ltd share?
Based on the latest closing data, the technical momentum for Pfizer Ltd is currently evaluated as Bearish. The stock is exhibiting an RSI (14) of 53.92, indicating it is trading in a neutral balanced zone. Key tracking supports are currently located near the daily pivots, with price relative to the 50 DMA (4588.73) defining immediate multi-day trend patterns.
What are the key resistance and support pivot points for Pfizer Ltd?
According to Classic Pivot Point methodologies, the core trading floor for Pfizer Ltd today centers at a Pivot Point (PP) of ₹4559.5. Upside resistance challenges are calculated at R1: ₹4616.4, R2: ₹4665.9, and R3: ₹4722.8. Conversely, if selling pressure intensifies, immediate floor support targets are positioned at S1: ₹4510, S2: ₹4453.1, and S3: ₹4403.6.
How does the fundamental ROE and P/E ratio look for Pfizer Ltd?
Pfizer Ltd is currently trading with a valuation metrics context of a Stock P/E of 136, against a core structural efficiency Return on Equity (ROE) standing at 19.8 %. This fundamental operational efficiency baseline is coupled with an EPS Rating of 50, allowing investors to track how corporate profitability trends align with current price discovery cycles on the National Stock Exchange (NSE).
Should I buy or sell Pfizer Ltd shares based on corporate rankings?
Our dynamic trade matrix suggests a status of: Symmetric Breakout Squeeze Play (Neutral / Monitor Closely). Pfizer Ltd is locke... For long-term portfolios, decision-making should match the stock's market performance profile, which currently displays an institutional Accumulation/Distribution (A/D) grade of D, a Relative Strength (RS) ranking of 24, and long-term trend backing from the TI65 indicator (Neutral pattern).